表紙
市場調查報告書
商品編碼
1040440

癌症疫苗的全球市場(2021年∼2027年)

Cancer Vaccine Market 2021-2027

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球癌症疫苗的市場規模在預測期間內預計將以13.8%的年複合成長率增長。

市場成長的主要因素有對技術進步的日益關注以及與癌症疫苗投資相關的癌症發病率增加等。

本報告提供全球癌症疫苗市場調查,提供市場概要,市場成長要素及阻礙因素分析,各類型·各技術·各終端用戶·各地區的分析,競爭情形,再加上主要企業的簡介等全面性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的見解與目前市場趨勢

第3章 競爭情形

  • 主要企業分析
    • Bristol-Myers Squibb
    • Eli Lilly and Co.
    • GlaxoSmithKline plc
    • Merck & Co. Inc.
    • Pfizer Inc.
  • 主要策略分析
  • COVID-19對主要企業的影響

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第5章 市場明細

  • 全球癌症疫苗市場:各類型
    • 預防疫苗
    • 治療用疫苗
  • 全球癌症疫苗市場:各技術
    • 樹突狀細胞疫苗
    • 整合型疫苗
    • 不活化疫苗
    • 減毒活病毒疫苗
    • 重組載體疫苗
    • 其他
  • 全球癌症疫苗市場:各終端用戶
    • 醫院·診所
    • 研究機關
    • 製藥·生物科技企業
    • 其他

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 其他地區

第7章 企業簡介

  • AduroBioTech, Inc.
  • Advaxis Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Dendreon Pharmaceuticals LLC
  • Dynavax Technologies Corp.
  • F. Hoffmann-La Roche AG
  • Generex Biotechnology Corp.
  • Immunocellular Therapeutics, Ltd.
  • Moderna, Inc.
  • OSE Immunotherapeutics SA
  • Sanofi SA
  • Vaccinogen, Inc.
  • Welland Medical Ltd.
目錄
Product Code: OMR2023991

Global Cancer Vaccine Market Size, Share &Trends Analysis Report by Type (Preventive Vaccines and Therapeutic Vaccines), By Technology (Dendritic Cell Vaccines, Conjugate Vaccines, Inactive Vaccines, Live Attenuated Vaccines, Recombinant Vector Vaccines, and Others), and By End-User (Hospitals and Clinics, Research Institutes, Pharmaceuticals &Biotechnology Companies, and Others) Forecast Period, 2021-2027

The global cancer vaccine market is anticipated to grow at a substantial CAGR of 13.8% during the forecast period. The market is set to display impressive growth during the forecast period with some key trends emerging, such as the growing focus on technological advancements in cancer vaccines and rising incidences associated with cancer along with investments that are made in the cancer vaccines. The cancer vaccine market is focused on the production of a vaccine that boosts the body's immune system to fight against cancer.

The global cancer vaccine market suffered a downfall during the COVID-19 pandemic as most of the economic activities were halted during Q1 and Q2 2020. Due to increasing cases related to COVID-19 across the global healthcare systems had increased their focus on suppressing this disease, which in turn has resulted in a delay of diagnosis, and treatment for other diseases such as cancer. However, it is anticipated to gain momentum in the future.

The global cancer vaccine market is segmented based on type, technology, and end-user. By type, the market is segmented into preventive vaccines and therapeutic vaccines. The preventive vaccine segment holds a significant market share in 2020. Based on the technology segment, the market is segmented into dendritic vaccines, conjugate vaccines, inactivated vaccines, live attenuated vaccines, recombinant vector vaccines, and others. Further, based on the end-user segment, the market is segmented into hospitals and clinics, research institutes, pharmaceuticals and biotechnology companies, and others.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific is expected to have the fastest-growing region in the market. Increasing hospitals and clinics with advanced medical equipment's which was once a stronghold of the US and a few European economies such as France, Italy, and Germany, is set to expand to emerging economies, to be planned predominantly in the Asia-Pacific region. The growing acceptance of cancer vaccines in the Asian economies of Japan, South Korea, Taiwan, and China, which involve providing effective treatment, is set to increase the demand for a cancer vaccine.

Further, Bristol-Myers Squibb, Merck &Co. Inc., GlaxoSmithKline plc, Eli Lilly and Company, Pfizer Inc., among others are the key players in the cancer vaccine market, that are adopting different strategies such as new product launches and approvals, mergers, and acquisitions, partnerships, and collaborations, among others. For instance, in May 2018, Merck &Co. Inc., and Moderna Therapeutics had expanded their collaborations to make and commercialize novel personalized messenger RNA (mRNA) cancer vaccines to provide effective treatment.

Research Methodology

The market study of the global cancer vaccine market is incorporated by extensive primary and secondary research conducted by the research team at OMR Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market

Whitepapers, research papers, and news blogs

Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Cancer Vaccine Market Research And Analysis By Type

Global Cancer Vaccine Market Research And Analysis By Technology

Global Cancer Vaccine Market Research And Analysis By End-User

The Report Covers

Comprehensive research methodology of the global cancer vaccine market

This report also includes a detailed and extensive market overview with key analyst insights

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations

Analysis of regional regulations and other government policies impacting the global cancer vaccine market

Insights about market determinants that are stimulating the global cancer vaccine market

Detailed and extensive market segments with the regional distribution of forecasted revenues

Extensive profiles and recent developments of market players

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Cancer Vaccine Industry
  • Recovery Scenario of Global Cancer Vaccine Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Bristol-Myers Squibb
      • 3.1.1.1. Overview
      • 3.1.1.2. Financial Analysis
      • 3.1.1.3. SWOT Analysis
      • 3.1.1.4. Recent Developments
    • 3.1.2. Eli Lilly and Co.
      • 3.1.2.1. Overview
      • 3.1.2.2. Financial Analysis
      • 3.1.2.3. SWOT Analysis
      • 3.1.2.4. Recent Developments
    • 3.1.3. GlaxoSmithKline plc
      • 3.1.3.1. Overview
      • 3.1.3.2. Financial Analysis
      • 3.1.3.3. SWOT Analysis
      • 3.1.3.4. Recent Developments
    • 3.1.4. Merck & Co. Inc.
      • 3.1.4.1. Overview
      • 3.1.4.2. Financial Analysis
      • 3.1.4.3. SWOT Analysis
      • 3.1.4.4. Recent Developments
    • 3.1.5. Pfizer Inc.
      • 3.1.5.1. Overview
      • 3.1.5.2. Financial Analysis
      • 3.1.5.3. SWOT Analysis
      • 3.1.5.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of Covid on key players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Cancer Vaccine Market by Type
    • 5.1.1. Preventive Vaccines
    • 5.1.2. Therapeutic vaccines
  • 5.2. Global Cancer Vaccine Market by Technology
    • 5.2.1. Dendritic Cell Vaccines
    • 5.2.2. Conjugate Vaccines
    • 5.2.3. Inactivated Vaccines
    • 5.2.4. Live Attenuated Vaccines
    • 5.2.5. Recombinant Vector Vaccines
    • 5.2.6. Others
  • 5.3. Global Cancer Vaccine Marketby End-User
    • 5.3.1. Hospitals and Clinics
    • 5.3.2. Research Institutes
    • 5.3.3. Pharmaceuticals & Biotechnology Companies
    • 5.3.4. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. AduroBioTech, Inc.
  • 7.2. Advaxis Inc.
  • 7.3. Amgen Inc.
  • 7.4. Astellas Pharma Inc.
  • 7.5. AstraZeneca PLC
  • 7.6. Dendreon Pharmaceuticals LLC
  • 7.7. Dynavax Technologies Corp.
  • 7.8. F. Hoffmann-La Roche AG
  • 7.9. Generex Biotechnology Corp.
  • 7.10. Immunocellular Therapeutics, Ltd.
  • 7.11. Moderna, Inc.
  • 7.12. OSE Immunotherapeutics SA
  • 7.13. Sanofi SA
  • 7.14. Vaccinogen, Inc.
  • 7.15. Welland Medical Ltd.

LIST OF TABLES

1. GLOBAL CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027($ MILLIONS)

2. GLOBAL PREVENTIVE VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLIONS)

3. GLOBAL THERAPEUTIC VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLIONS)

4. GLOBAL CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027($ MILLIONS)

5. GLOBAL DENDRITIC CELL VACCINES IN CANCER VACCINE MARKET MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLIONS)

6. GLOBAL CONJUGATE VACCINES IN CANCER VACCINE MARKETMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLIONS)

7. GLOBAL INACTIVATED VACCINES IN CANCER VACCINE MARKET MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLIONS)

8. GLOBAL LIVE ATTENUATED VACCINES IN CANCER VACCINE MARKET MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLIONS)

9. GLOBAL RECOMBINANT VECTOR VACCINES IN CANCER VACCINE MARKET MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLIONS)

GLOBAL OTHERS VACCINES IN CANCER VACCINE MARKET MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLIONS)

10. GLOBAL CANCER VACCINES MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027($ MILLIONS)

11. GLOBAL CANCER VACCINES IN HOSPITALS & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLIONS)

12. GLOBAL CANCER VACCINES IN RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLIONS)

13. GLOBAL CANCER VACCINES IN PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLIONS)

14. GLOBAL CANCER VACCINES IN OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLIONS)

15. GLOBAL CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027($ MILLIONS)

  • 16. NORTH AMERICAN CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027($ MILLION)
  • 17. NORTH AMERICAN CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027($ MILLION)
  • 18. NORTH AMERICAN CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027($ MILLION)
  • 19. NORTH AMERICAN CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
  • 20. EUROPEAN CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027($ MILLION)
  • 21. EUROPEAN CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027($ MILLION)
  • 22. EUROPEAN CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027($ MILLION)
  • 23. EUROPEAN CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
  • 24. ASIA-PACIFIC CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027($ MILLION)
  • 25. ASIA-PACIFIC CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027($ MILLION)
  • 26. ASIA-PACIFIC CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027($ MILLION)
  • 27. ASIA-PACIFIC CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
  • 28. REST OF THE WORLD CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027($ MILLION)
  • 29. REST OF THE WORLD CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027($ MILLION)
  • 30. REST OF THE WORLD CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL CANCER VACCINE MARKET, 2020-2027 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL CANCER VACCINE MARKET BY SEGMENT, 2020-2027 ($ MILLION)
  • 3. RECOVERY OF GLOBAL CANCER VACCINE MARKET, 2021-2027 (%)

4. GLOBAL CANCER VACCINES MARKET RESEARCH AND ANALYSIS BY TYPE, 2020 AND 2027(IN %)

5. GLOBAL CANCER VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020 AND 2027(IN %)

6. GLOBAL CANCER VACCINES MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020 AND 2027(IN %)

7. GLOBAL CANCER VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2020 AND 2027(IN %)

8. US CANCER VACCINES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLIONS)

9. CANADA CANCER VACCINES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLIONS)

10. UK CANCER VACCINES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLIONS)

11. FRANCE CANCER VACCINES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLIONS)

12. GERMANY CANCER VACCINES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLIONS)

13. ITALY CANCER VACCINES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLIONS)

14. SPAIN CANCER VACCINES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLIONS)

15. ROE CANCER VACCINES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLIONS)

16. INDIA CANCER VACCINES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLIONS)

17. CHINA CANCER VACCINES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLIONS)

18. JAPAN CANCER VACCINES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLIONS)

19. SOUTH KOREACANCER VACCINES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLIONS)

20. REST OF ASIA-PACIFIC CANCER VACCINES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLIONS)

21. REST OF THE WORLD CANCER VACCINES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLIONS)